Summitek’s pharmaceutical ointment composite tubes have completed registration on the National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) platform for drug substance and pharmaceutical excipient and packaging material registration. The registration number is B20240000745, with an A status, indicating approval through associated review.
This milestone supports pharmaceutical manufacturers seeking suitable packaging materials for drug registration and product development, demonstrating Summitek’s continued commitment to compliance and pharmaceutical packaging solutions.

Pharmaceutical ointment tubes are widely used for topical medication packaging. For pharmaceutical manufacturers, selecting suitable packaging materials involves more than meeting product requirements. Registration status and supporting documentation are also important considerations during the drug registration process.
With its registered pharmaceutical ointment composite tubes, Summitek can assist pharmaceutical customers by providing relevant supporting documentation and cooperating with their registration and packaging coordination needs. This support helps customers move forward with their projects more efficiently.
In addition to pharmaceutical packaging, Summitek manufactures tube packaging for the cosmetics and personal care industries, serving customers with different product and packaging requirements.
We welcome inquiries from pharmaceutical manufacturers, cosmetics brands, and personal care companies seeking tube packaging products and customized packaging solutions.
Summitek is committed to tube packaging manufacturing, supporting customers with product solutions and responsive service across multiple industries.
To learn more about our pharmaceutical composite tubes, registration information, or other tube packaging solutions, please visit the Summitek official website or contact our team for further information.